stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Gratuito - Play StoreApp Store
InstallareInstallare
logo
Dow:  
Nasdaq:  
S&P 500:  
Atento S.A. Ordinary SharesATTO
$15.512.11%0.32

Atento S.A. Ordinary Shares (ATTO)

Date: 2026-11-02 16:00O: 15.39H: 16.23L: 15.37C: 15.43Vol: 6.662k
Precedente Chiudi:
$15.19
Aprire:
$15.39
Volume 24 ore:
15,376
Volume relativo:
0.05
Capitalizzazione di mercato:
$708.05M
Reddito:
$1.42B
Utile/perdita netta:
-$140.69M
Rapporto P/E:
-
EPS:
-$9.74
Flusso di cassa netto:
$10.77M
1W Prestazione:
+11.74%
1M Prestazione:
-9.67%
6M Prestazione:
+3,190%
1Y Prestazione:
+3,190%
Intervallo 1D:
$15.27$16.23
Intervallo di 1 settimana:
$13.63$16.83
Portata 52W:
$0.4248$28.00

Profilo aziendale di Atento S.A. Ordinary Shares (ATTO)

Nome
Atento S.A. Ordinary Shares
Settore
Healthcare
Industria
Biotechnology
Telefono
-
Indirizzo
4, Rue Lou Hemmer, Findel, USA
Dipendente
150,000
Prossima data di guadagno
2026-12-02
Ultimi documenti SEC
SEC
Discussioni di ATTO su X
X

Confronta ATTO con VRTX, REGN, MRNA, ARGX, ONC

AzioniCap. di mercatoRedditoReddito nettoFlusso di cassaEPS
ATTO
Atento S.A. Ordinary Shares
$708.05M$1.42B-$140.69M$10.77M-$9.74
VRTX
Vertex Pharmaceuticals Inc
$143.11B$12.34B$4.34B$3.71B$16.87
REGN
Regeneron Pharmaceuticals Inc
$98.75B$14.92B$4.42B$3.79B$41.04
MRNA
Moderna Inc
$89.06B$2.23B-$3.19B-$1.60B-$8.15
ARGX
Argen X Se Adr
$55.67B$4.16B$1.29B$734.26M$19.58
ONC
Beone Medicines Ltd Adr
$41.68B$5.76B$514.49M$1.10B$4.48

Atento S.A. Ordinary Shares Azioni (ATTO) Upgrade e downgrade

DataAzioneAnalistaModifica della valutazione
2026-08-31IniziatoCitigroupBuy
2026-08-31IniziatoLeerink PartnersOutperform
2026-08-31IniziatoMorgan StanleyOverweight
2026-08-31IniziatoRBC Capital MktsOutperform

Atento S.A. Ordinary Shares Azioni (ATTO) Dati Finanziari

Non sono disponibili dati finanziari per Atento S.A. Ordinary Shares (ATTO). Controlla altri titoli per ulteriori informazioni.

Atento S.A. Ordinary Shares Azioni (ATTO) insider trading

  • WALSH COLINAug 06 '26
    Director
    Transazione
    Buy
    Costo
    $17.00
    #Azioni
    500,000
    Valore ($)
    8,500,000
    #Azioni Totale
    3,020,632
  • 10% Owner
    Transazione
    Buy
    Costo
    $17.00
    #Azioni
    382,352
    Valore ($)
    6,499,984
    #Azioni Totale
    4,181,367
  • 10% Owner
    Transazione
    Buy
    Costo
    $17.00
    #Azioni
    400,000
    Valore ($)
    6,800,000
    #Azioni Totale
    1,182,854
  • 10% Owner
    Transazione
    Buy
    Costo
    $17.00
    #Azioni
    200,000
    Valore ($)
    3,400,000
    #Azioni Totale
    982,854
  • 10% Owner
    Transazione
    Buy
    Costo
    $17.00
    #Azioni
    588,235
    Valore ($)
    9,999,995
    #Azioni Totale
    6,154,213
  • Former 10% Owner
    Transazione
    Buy
    Costo
    $17.00
    #Azioni
    500,000
    Valore ($)
    8,500,000
    #Azioni Totale
    3,020,632
  • SanofiAug 06 '26
    10% Owner
    Transazione
    Buy
    Costo
    $17.00
    #Azioni
    300,000
    Valore ($)
    5,100,000
    #Azioni Totale
    1,082,855
  • WALSH COLINAug 05 '26
    Director
    Transazione
    Buy
    Costo
    $21.00
    #Azioni
    85,000
    Valore ($)
    1,785,000
    #Azioni Totale
    85,000
  • WALSH COLINAug 05 '26
    Director
    Transazione
    Sale
    Costo
    $21.28
    #Azioni
    105,807
    Valore ($)
    2,251,658
    #Azioni Totale
    0
  • Former 10% Owner
    Transazione
    Buy
    Costo
    $21.00
    #Azioni
    85,000
    Valore ($)
    1,785,000
    #Azioni Totale
    85,000
Commercio internoRelazioneDataTransazioneCosto#AzioniValore ($)#Azioni Totale
WALSH COLINDirectorAug 06 '26Buy$17.00500,0008,500,0003,020,632
venBio Global Strategic Fund I10% OwnerAug 06 '26Buy$17.00382,3526,499,9844,181,367
Redmile Group, LLC10% OwnerAug 06 '26Buy$17.00400,0006,800,0001,182,854
Redmile Group, LLC10% OwnerAug 06 '26Buy$17.00200,0003,400,000982,854
Frazier Life Sciences XI, L.P.10% OwnerAug 06 '26Buy$17.00588,2359,999,9956,154,213
GOLDMAN SACHS GROUP INCFormer 10% OwnerAug 06 '26Buy$17.00500,0008,500,0003,020,632
Sanofi10% OwnerAug 06 '26Buy$17.00300,0005,100,0001,082,855
WALSH COLINDirectorAug 05 '26Buy$21.0085,0001,785,00085,000
WALSH COLINDirectorAug 05 '26Sale$21.28105,8072,251,6580
GOLDMAN SACHS GROUP INCFormer 10% OwnerAug 05 '26Buy$21.0085,0001,785,00085,000

Atento S.A. Ordinary Shares Borsa (ATTO) Ultime notizie

Oct 21, 2026
Oct 21, 2026
Oct 16, 2026
Oct 16, 2026
Oct 08, 2026
Oct 08, 2026
Oct 08, 2026
Oct 08, 2026
Sep 02, 2026
Sep 02, 2026
Aug 28, 2026
Aug 28, 2026
Aug 28, 2026
Aug 28, 2026
Aug 20, 2026
Aug 20, 2026
Aug 13, 2026
Aug 13, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 11, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 10, 2026
Aug 09, 2026
Aug 09, 2026
Aug 08, 2026
Aug 08, 2026
Aug 06, 2026
Aug 06, 2026
Aug 06, 2026
Aug 06, 2026
Aug 06, 2026
Aug 06, 2026
Aug 05, 2026
Aug 05, 2026
Aug 05, 2026
Aug 05, 2026
Aug 05, 2026
Aug 05, 2026
Aug 05, 2026
Aug 05, 2026
Aug 04, 2026
Aug 04, 2026
Aug 04, 2026
Aug 04, 2026
Aug 04, 2026
Aug 04, 2026
Aug 04, 2026
Aug 04, 2026
Aug 04, 2026
Aug 04, 2026
Jul 31, 2026
Jul 31, 2026
Jul 30, 2026
Jul 30, 2026
Jul 24, 2026
Jul 24, 2026
Jul 14, 2026
Jul 14, 2026
Jul 14, 2026
Jul 14, 2026
Apr 21, 2026
Apr 21, 2026
Apr 19, 2026
Apr 19, 2026
Mar 15, 2026
Mar 15, 2026
Mar 05, 2022
Mar 05, 2022
Jul 15, 2016
Jul 15, 2016
May 24, 1998
May 24, 1998

Simile a ATTO